Inside Immatics / Scientific Advisory Board

Scientific Advisory Board

Immatics’ Scientific Advisory Board is made up of pioneering scientists with
expertise ranging across areas such as immuno-oncology, adoptive cell therapies,
clinical oncology and cancer biology.

Anne Kerber, M.D.

Senior Vice President Head of Cell Therapy Development Bristol Myers Squibb
Cassian Yee, M.D.

MD Anderson Cancer Center US
Crystal Mackall, M.D.

Co-Chair
Stanford University US
Dirk Busch, Prof. Dr. med.

Technical University of Munich Germany
Gwendolyn Binder, Ph.D.

Cabaletta Bio US
Hans-Georg Rammensee, Ph.D.

Eberhard Karls University Germany
Hidde Ploegh, Ph.D.

Boston Children’s Hospital US
Patrick Hwu, M.D.

Co-Chair Moffitt Cancer Center US
Roland Kontermann, Ph.D.

University of Stuttgart Germany